$16.63
-0.12-0.72%
At close: -
$16.63
0.000.00%
After Hours: Feb 21, 5:50 PM EDT
Comments
Loading...
Centessa Pharmaceuticals (CNTA) Forecast
NewsEarningsCentessa Pharmaceuticals (CNTA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCentessa Pharmaceuticals (NASDAQ:CNTA) Stock Quotes, Forecast and News Summary
Centessa Pharmaceuticals Stock (NASDAQ: CNTA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Centessa Pharmaceuticals (CNTA) stock?
You can purchase shares of Centessa Pharmaceuticals (NASDAQ:CNTA) through any online brokerage.
Who are Centessa Pharmaceuticals (CNTA) competitors?
Other companies in Centessa Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), Protagonist Therapeutics (NASDAQ:PTGX) and Mesoblast (NASDAQ:MESO).
What is the forecast, or price target, for Centessa Pharmaceuticals (CNTA) stock?
Centessa Pharmaceuticals has a consensus price target of $17.78.
What is the current price for Centessa Pharmaceuticals (CNTA)?
The stock price for Centessa Pharmaceuticals (NASDAQ: CNTA) is $16.63 last updated February 21, 2025 at 5:50 PM EST.
Does Centessa Pharmaceuticals (CNTA) pay a dividend?
There are no upcoming dividends for Centessa Pharmaceuticals.
When is Centessa Pharmaceuticals (NASDAQ:CNTA) reporting earnings?
Centessa Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 12, 2025.
Is Centessa Pharmaceuticals (CNTA) going to split?
There is no upcoming split for Centessa Pharmaceuticals.
What sector and industry does Centessa Pharmaceuticals (CNTA) operate in?
Centessa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.